Invasight logo

Invasight

Clinical biotech firm focused on revolutionizing cell invasion research.

2

Funding Rounds

$4.7m

Money raised

Overview

Clinical biotech firm focused on revolutionizing cell invasion research.

Funding series

Funding Series Analysis

The company Invasight has raised a total of $4.7m in funding over 2 rounds.

Key Insights:

  • Invasight June 2022 Seed Funding Round: $4.7m
Invasight logo
Invasight June 2022 Seed Funding Round $4.7m

Industries

Invasight is active in the following industries: